Delivery Order SPE2DB24D3013-SPE2DB25FFQPJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This firm fixed-price delivery order, valued at $20,983.35, was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.15 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.9 mg on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a purchase of a hormone replacement therapy medication supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.18 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This firm fixed-price delivery order, valued at $22,825.36, is scheduled for completion by September 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating it was competitively awarded in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,182.81 for 100 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg with a ceiling value of $1,052.49. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,934.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) with a ceiling value of $2,121.76. This non-competitive, firm fixed-price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,674.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.45 mg on September 16, 2025, with completion expected by September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating competitive...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQPJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,324.91 to supply 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. The contract, issued on September 15, 2025, with completion targeted for September 16, 2025, utilizes firm fixed-price delivery order pricing under a non-competitive set-aside basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies to military healthcare systems worldwide. Through this arrangement, AmerisourceBergen fulfills medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, supporting the delivery of critical medications across multiple therapeutic domains to military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/15/25 |